[
  {
    "ts": null,
    "headline": "Bicara: Stock Decline On FICERA Abstract Release Creates Buying Opportunity",
    "summary": "Bicara: Stock Decline On FICERA Abstract Release Creates Buying Opportunity",
    "url": "https://finnhub.io/api/news?id=56eb7dcbb9f55f180df50c5e23719066a0e4c161723b428ef0a391dedaf92d4d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748017055,
      "headline": "Bicara: Stock Decline On FICERA Abstract Release Creates Buying Opportunity",
      "id": 134679108,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=56eb7dcbb9f55f180df50c5e23719066a0e4c161723b428ef0a391dedaf92d4d"
    }
  },
  {
    "ts": null,
    "headline": "Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics",
    "summary": "Merus stock rocketed — and hammered Bicara — after unveiling promising new results for its experimental head-and-neck cancer treatment.",
    "url": "https://finnhub.io/api/news?id=593b02873178ce81eeef93dd62d26065cf191b70494cf9a232a3090b74d95e4b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748009749,
      "headline": "Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics",
      "id": 134685775,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merus stock rocketed — and hammered Bicara — after unveiling promising new results for its experimental head-and-neck cancer treatment.",
      "url": "https://finnhub.io/api/news?id=593b02873178ce81eeef93dd62d26065cf191b70494cf9a232a3090b74d95e4b"
    }
  },
  {
    "ts": null,
    "headline": "Merck Issues Statement On Potential Reduced Dosing Recommendation For Gardasil 9",
    "summary": "Merck & Co Inc: * MERCK STATEMENT ON A POTENTIAL REDUCED DOSINGRECOMMENDATION FORGARDASIL®9 * AFFIRMED POSITION REGARDING ALTERNATE DOSING REGIMENS FORGARDASIL®9 FOR...",
    "url": "https://finnhub.io/api/news?id=597a9ae6571d3a00004caab9c274317b9d89cb96fd688a30c7a8bfae4a3733ea",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748009287,
      "headline": "Merck Issues Statement On Potential Reduced Dosing Recommendation For Gardasil 9",
      "id": 134670338,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Merck & Co Inc: * MERCK STATEMENT ON A POTENTIAL REDUCED DOSINGRECOMMENDATION FORGARDASIL®9 * AFFIRMED POSITION REGARDING ALTERNATE DOSING REGIMENS FORGARDASIL®9 FOR...",
      "url": "https://finnhub.io/api/news?id=597a9ae6571d3a00004caab9c274317b9d89cb96fd688a30c7a8bfae4a3733ea"
    }
  },
  {
    "ts": null,
    "headline": "Merck: Dividend Near A 12-Year High, But I Won't Buy - Here's Why",
    "summary": "Merck: Dividend Near A 12-Year High, But I Won't Buy - Here's Why",
    "url": "https://finnhub.io/api/news?id=489b5ac71321129378a0192ccbbfa797b8bf1ea0dd157b78559489f8f7326ae1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747998733,
      "headline": "Merck: Dividend Near A 12-Year High, But I Won't Buy - Here's Why",
      "id": 134661603,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=489b5ac71321129378a0192ccbbfa797b8bf1ea0dd157b78559489f8f7326ae1"
    }
  },
  {
    "ts": null,
    "headline": "Merck: Defensive Yield Meets Long-Term Optionality",
    "summary": "Merck is expanding in oncology, immunology, and vaccines through acquisitions and R&D. Find out what makes MRK a stable GARP buy in a volatile macro environment.",
    "url": "https://finnhub.io/api/news?id=7b45ec49c7c963c41c1cff85138a8c914dbcfbcdf3d1ff9eb3f5611bdbf85bf1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747998337,
      "headline": "Merck: Defensive Yield Meets Long-Term Optionality",
      "id": 134661481,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1483054494/image_1483054494.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Merck is expanding in oncology, immunology, and vaccines through acquisitions and R&D. Find out what makes MRK a stable GARP buy in a volatile macro environment.",
      "url": "https://finnhub.io/api/news?id=7b45ec49c7c963c41c1cff85138a8c914dbcfbcdf3d1ff9eb3f5611bdbf85bf1"
    }
  },
  {
    "ts": null,
    "headline": "Merck : Statement on a Potential Reduced Dosing Recommendation for GARDASIL®9 - Merck.com",
    "summary": "May 23, 2025 8:00 am ET RAHWAY, N.J., May 23, 2025 - Merck , known as MSD outside of the United States and Canada, today affirmed its position regarding alternate dosing regimens for...",
    "url": "https://finnhub.io/api/news?id=23aa55b0001bc9179e35cab96ed2ab39607a60cfba0778faafaf708479d122cf",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747987385,
      "headline": "Merck : Statement on a Potential Reduced Dosing Recommendation for GARDASIL®9 - Merck.com",
      "id": 134657832,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "May 23, 2025 8:00 am ET RAHWAY, N.J., May 23, 2025 - Merck , known as MSD outside of the United States and Canada, today affirmed its position regarding alternate dosing regimens for...",
      "url": "https://finnhub.io/api/news?id=23aa55b0001bc9179e35cab96ed2ab39607a60cfba0778faafaf708479d122cf"
    }
  },
  {
    "ts": null,
    "headline": "3 Dow Jones Stocks on Our Watchlist",
    "summary": "The Dow Jones (^DJI) includes some of the most reliable stocks in the market, and while not all are equal, a few continue to shine. These companies are leveraging their strengths to maintain leadership and reward investors.",
    "url": "https://finnhub.io/api/news?id=33426a74ecbe0c5da21df7b059164bc2c6581d9572ee265f2ccbf15dbeaeea33",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747974759,
      "headline": "3 Dow Jones Stocks on Our Watchlist",
      "id": 134658427,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The Dow Jones (^DJI) includes some of the most reliable stocks in the market, and while not all are equal, a few continue to shine. These companies are leveraging their strengths to maintain leadership and reward investors.",
      "url": "https://finnhub.io/api/news?id=33426a74ecbe0c5da21df7b059164bc2c6581d9572ee265f2ccbf15dbeaeea33"
    }
  },
  {
    "ts": null,
    "headline": "Strokes and Heart Attacks Kill. New Drugs Are Coming to Prevent Them.",
    "summary": "Strokes and Heart Attacks Kill. New Drugs Are Coming to Prevent Them.",
    "url": "https://finnhub.io/api/news?id=11df618cbe1d12188be9b8aae114a9efc775459c4e45dfee164008579f03434a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747969200,
      "headline": "Strokes and Heart Attacks Kill. New Drugs Are Coming to Prevent Them.",
      "id": 134662223,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Strokes and Heart Attacks Kill. New Drugs Are Coming to Prevent Them.",
      "url": "https://finnhub.io/api/news?id=11df618cbe1d12188be9b8aae114a9efc775459c4e45dfee164008579f03434a"
    }
  }
]